Showing 8,841 - 8,860 results of 226,405 for search '(( a ((((teer decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a larger decrease ))', query time: 1.68s Refine Results
  1. 8841

    Image 6_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  2. 8842

    Image 10_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  3. 8843

    The effect of decreasing recombinase expression on circuit performance. by Jack E. Bowyer (9874262)

    Published 2020
    “…The model predictions align qualitatively with our data, demonstrating a decline in circuit performance as recombinase expression decreases.…”
  4. 8844

    The locomotor activity decreased in the first extinction session. by Jian-Jun Zhang (334146)

    Published 2017
    “…<p>(a) Compared with the last acquisition, the locomotor activity decreased in the first extinction day (n = 47). …”
  5. 8845
  6. 8846
  7. 8847
  8. 8848
  9. 8849
  10. 8850
  11. 8851
  12. 8852
  13. 8853

    GA decreases CD11c expression. by Refik Pul (292867)

    Published 2013
    “…<p><b>A.</b> Significant decrease in CD11c expression after 24 h of GA treatment. …”
  14. 8854
  15. 8855
  16. 8856
  17. 8857
  18. 8858

    Image 3_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  19. 8859

    Image 6_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  20. 8860

    Image 7_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”